Cargando…
Pharmacological Effects of the Ruthenium Complex NAMI-A Given Orally to CBA Mice With MCa Mammary Carcinoma
NAMI-A, imidazolium trans-imidazoledimethylsulfoxidetetrachlororuthenate, is a ruthenium based compounds capable of inhibiting the growth of lung metastases of solid tumours in a number of experimental conditions.The aim of this study was to investigate the potential use of NAMI-A by the oral route...
Autores principales: | Zorzet, Sonia, Sorc, Alenka, Casarsa, Claudia, Cocchietto, Moreno, Sava, Gianni |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365250/ https://www.ncbi.nlm.nih.gov/pubmed/18475970 http://dx.doi.org/10.1155/MBD.2001.1 |
Ejemplares similares
-
Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties
por: Castellarin, Anna, et al.
Publicado: (2016) -
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
por: Vacca, A, et al.
Publicado: (2002) -
PtyNAMi: ptychographic nano-analytical microscope
por: Schropp, Andreas, et al.
Publicado: (2020) -
Microencapsulation of Bioactive Principles with an Airless Spray-Gun Suitable for Processing High Viscous Solutions
por: Cocchietto, Moreno, et al.
Publicado: (2013) -
Skin tumour incidence in CBA mice given fractionated exposures to low energy beta particles.
por: Hulse, E. V., et al.
Publicado: (1969)